Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 171 results found. Search for [ trials 500 ]

Results 20 to 40 of 171
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax

October 11, 2020
The minister also said that based on tests of over 2,000 patients during the trials at the Institute of Genomics and Integrative Biology (IGIB) and on testing in private labs, the test showed 96 per cent sensitivity and 98 per cent specificity

October 4, 2020
Health Minister Harsh Vardhan said a high-level expert group is going into all the aspects of vaccines and the health ministry is preparing a format in which states will submit lists of priority population groups

October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites

September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan

September 16, 2020
Former Wipro CEO and Managing Director Abidali Neemuchwala has joined Dallas Venture Partners (DVP) as a venture partner

September 16, 2020
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech

September 15, 2020
India Stock Market Highlights Today: Titan, followed by Sun Pharma, HDFC, ICICI Bank, Bajaj Finance, NTPC, HDFC Bank and M&M were among the major gainers on Sensex pack today. On the other hand, Tech Mahindra, HCL Tech, Kotak Bank, ITC and Bharti Airtel were among the laggards

September 11, 2020
Sensex rose 14 points to 38,854 and Nifty ended 15 points higher at 11,464

September 10, 2020
The Securities Issuance Committee of the board at its meeting held on Wednesday approved the floor price for the QIP at Rs 206.70 per equity share

September 9, 2020
Dow Jones opened higher as a rout in technology shares halted and investors shrugged off news that AstraZeneca had paused global trials of its experimental COVID-19 vaccine

PB Jayakumar
September 2, 2020
Mankind has been promoting DrOnA Health among doctors as a service to help them. Over 10,000 doctors are now using the facility. Another special feature of the app is that it allows doctors to have complete ownership of data.

September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine

Sumant Banerji
August 31, 2020
Most Chinese companies operating in India believe the brewing anti-China sentiment won't impact their long-term objectives in Indian market

Mudit Kapoor
August 26, 2020
Poonawalla's Serum Institute is the largest vaccine maker in the world and at the forefront in the race to make COVID-19 vaccine

August 21, 2020
RDIF CEO Kirill Dmitriev said that Russia currently has the capacity of 500 million doses per year, but plans to increase this capacity

New Delhi, August 19, 2020
COVID-19 pandemic: WHO lambasts 'vaccine nationalism' in last-resort attempt against hoardingNations that hoard possible COVID-19 vaccines while excluding others will deepen the pandemic, World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Tuesday, issuing a last-ditch call for countries to join a global vaccine pact. The WHO has an Aug. 31 deadline for wealthier nations to join the \"COVAX Global Vaccines Facility\" for sharing vaccine hopefuls with developing countries...

August 11, 2020
Several Latin American, Middle Eastern and Asian states have expressed an interest in purchasing the Russian vaccine, while several contracts have been finalised, says Kirill Dmitriyev, the head of the RDIF which finances the vaccine project

August 1, 2020
The Sanofi-GSK deal is for 100 million doses, at two per person, and gives the U.S. government an option to purchase an additional 500 million doses at an unspecified price

Associated Press
July 31, 2020
The United States will pay up to USD 2.1 billion for development including clinical trials, manufacturing, scale-up and delivery of its vaccine,'' the companies said in a statement. Sanofi will get the bulk of the funds

PAGES 2 OF 9  12345